Drug interactions
Betibeglogene autotemcel + Raltegravir
Severity: Major
Betibeglogene autotemcel and Raltegravir: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Antiretrovirals can impair the lentiviral transduction needed to manufacture this gene therapy. Residual raltegravir in the patient at apheresis could lead to a failed or less effective product.
What this interaction means in plain words
Betibeglogene autotemcel and Raltegravir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Antiretroviral activity inhibits lentiviral vector integration in collected cells.
What to do
Discontinue raltegravir at least one month before mobilization and until all apheresis cycles are finished. Confirm an appropriate interim HIV plan with an infectious disease specialist.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Betibeglogene autotemcel and Raltegravir, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Raltegravir
- Elvitegravir / cobicistat / emtricitabine / tenofovir df + Raltegravir Contraindicated
- Aluminum hydroxide / magnesium carbonate + Raltegravir Major
- Aluminum hydroxide / magnesium trisilicate + Raltegravir Major
- Aluminum hydroxide + Raltegravir Major
- Atidarsagene autotemcel + Raltegravir Major
- Cabotegravir + Raltegravir Major
Frequently asked questions
Can I take Betibeglogene autotemcel with Raltegravir?
MediHelp rates the interaction as major. Betibeglogene autotemcel and Raltegravir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Antiretrovirals can impair the lentiviral transduction needed to manufacture this gene therapy. Residual raltegravir in the patient at apheresis could lead to a failed or less effective product.
How serious is the interaction between Betibeglogene autotemcel and Raltegravir?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue raltegravir at least one month before mobilization and until all apheresis cycles are finished. Confirm an appropriate interim HIV plan with an infectious disease specialist.
What other medicines interact with Raltegravir?
MediHelp also lists interactions of Raltegravir with, for example, Elvitegravir / cobicistat / emtricitabine / tenofovir df, Aluminum hydroxide / magnesium carbonate, Aluminum hydroxide / magnesium trisilicate. The full list is on the Raltegravir page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
